Literature DB >> 8853064

Splenomegaly at a United States County Hospital: diagnostic evaluation of 170 patients.

R A O'Reilly1.   

Abstract

Splenomegaly was studied at a municipal teaching hospital in an 11-year retrospective review. The 170 patients were classified into six diagnostic groups. The associated clinical and laboratory features were tested for statistical association (X2), to determine predictive values. Hepatic diseases caused 36% of the splenomegaly; hematologic, 35%; infectious diseases (ID), 16%; inflammatory, 5%; primary splenic, 4%; and other, 3%. The acquired immunodeficiency syndrome (AIDS) occurred in 54% of patients with ID. Hematologic diseases were significantly associated (P < 0.01) with massive splenomegaly, left upper quadrant (LUQ) abdominal tenderness, and all blood "cytoses." The most common disease with massive splenomegaly was myelofibrosis. Surprisingly, hepatic diseases caused 29% of massive splenomegaly. Hepatic diseases were significantly associated (P < 0.01) with hepatomegaly, abnormal liver-function tests (LFT), and blood "cytopenias." Compared with previous reports, both congestive heart failure and endocarditis now rarely cause splenomegaly. All blood "cytopenias" had highly significant associations (P < 0.01) only with hepatic diseases, which suggests that hypersplenism remains a useful concept for the splenomegaly of liver disease.

Entities:  

Mesh:

Year:  1996        PMID: 8853064     DOI: 10.1097/00000441-199610000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  9 in total

1.  Determination of intact splenic weight based on morcellated weight.

Authors:  R M Walsh; B Chand; J Brodsky; B T Heniford
Journal:  Surg Endosc       Date:  2003-05-20       Impact factor: 4.584

2.  Assessing splenic enlargement on CT by unidimensional measurement changes in patients with colorectal liver metastases.

Authors:  Breanna J Joiner; Amber L Simpson; Julie N Leal; Michael I D'Angelica; Richard K G Do
Journal:  Abdom Imaging       Date:  2015-10

3.  Splenomegaly in 2,505 patients at a large university medical center from 1913 to 1995. 1963 to 1995: 449 patients.

Authors:  R A O'Reilly
Journal:  West J Med       Date:  1998-08

4.  Splenomegaly in 2,505 patients in a large university medical center from 1913 to 1995. 1913 to 1962: 2,056 patients.

Authors:  R A O'Reilly
Journal:  West J Med       Date:  1998-08

5.  Assessing splenomegaly: automated volumetric analysis of the spleen.

Authors:  Marius George Linguraru; Jesse K Sandberg; Elizabeth C Jones; Ronald M Summers
Journal:  Acad Radiol       Date:  2013-03-25       Impact factor: 3.173

Review 6.  Splenomegaly in Children and Adolescents.

Authors:  Meinolf Suttorp; Carl Friedrich Classen
Journal:  Front Pediatr       Date:  2021-07-09       Impact factor: 3.418

7.  Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes.

Authors:  Tariq I Mughal; Kris Vaddi; Nicholas J Sarlis; Srdan Verstovsek
Journal:  Int J Gen Med       Date:  2014-01-29

8.  Splenomegaly - Diagnostic validity, work-up, and underlying causes.

Authors:  Emelie Curovic Rotbain; Dennis Lund Hansen; Ove Schaffalitzky de Muckadell; Flemming Wibrand; Allan Meldgaard Lund; Henrik Frederiksen
Journal:  PLoS One       Date:  2017-11-14       Impact factor: 3.240

9.  Splenomegaly, hypersplenism and peripheral blood cytopaenias in patients with classical Anderson-Fabry disease.

Authors:  João Paulo Oliveira; Carmen Valbuena; António Baldaia Moreira; Elsa Fonseca; Carlos Soares; Elisa Leão Teles; Stephen Waldek
Journal:  Virchows Arch       Date:  2008-09-02       Impact factor: 4.535

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.